Monroe, LA, United States of America

Paul Sylvester

This inventor holds 1 USPTO granted patent. Top assignee: University of Louisiana at Monroe. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Sylvester. Retrieved from https://idiyas.com/inventor/paul-sylvester-j6heftac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Paul Sylvester

Introduction

Paul Sylvester is a notable inventor based in Monroe, Louisiana. He has made significant contributions to the field of cancer treatment through his innovative research. His work focuses on the development of anticancer tobacco cembranoids, which presents a novel approach to combating cancer.

Latest Patents

Paul Sylvester holds a patent for a method of treating cancer, which includes delivering an amount of at least one compound to an area containing a cancer cell. This patent outlines both the compound and the method of preparing it, showcasing his commitment to advancing medical science. He has 1 patent to his name, reflecting his dedication to innovation in healthcare.

Career Highlights

Sylvester is affiliated with the University of Louisiana at Monroe, where he continues to engage in groundbreaking research. His academic background and professional experience have positioned him as a key figure in the development of cancer treatment methodologies.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues such as Khalid A El Sayed and Girish Shah. These partnerships have enhanced his research efforts and contributed to the advancement of cancer treatment strategies.

Conclusion

Paul Sylvester's work exemplifies the spirit of innovation in the medical field. His contributions to cancer treatment through the development of anticancer tobacco cembranoids highlight the importance of research and collaboration in addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…